An ultrastructural and immunogold localization study of proteoglycans associated with the osteocytes of fetal bone in osteogenesis imperfecta
- PMID: 8661486
- DOI: 10.1007/BF02509444
An ultrastructural and immunogold localization study of proteoglycans associated with the osteocytes of fetal bone in osteogenesis imperfecta
Abstract
Osteogenesis imperfecta (OI) is a rare, heterogeneous, inherited connective tissue disorder frequently caused by abnormalities of type I collagen. It is characterized by bone fragility, osteopenia, and progressive skeletal deformities. Electron microscopy of three OI type II fetal bone samples revealed numerous large osteocyte lacunae. In addition, there was a perilacunar osteoid-like band of collagen surrounding the osteocytes, which was unmineralized and morphologically unusual. Furthermore, large osteocyte lacunae contained fine particles and filamentous material similar to the expected ultrastructural appearance of proteoglycans. More detailed examination was carried out using histochemical and immunogold localization of proteoglycans at light and ultrastructural levels. These tests and the use of electron probe X-ray microanalysis confirmed that the material in the osteocyte lacunae was proteoglycan. In contrast, in the age- and site-matched normal fetal bone, all the osteocyte lacunae appeared negative for proteoglycan. Proteoglycans are regarded as inhibitors of calcification. Our observation of substantial amounts of proteoglycan in abnormally enlarged osteocytic lacunae of some OI fetal bone suggests association with the abnormal bone of this particular subtype of OI type II.
Similar articles
-
Increased Osteocyte Lacunae Density in the Hypermineralized Bone Matrix of Children with Osteogenesis Imperfecta Type I.Int J Mol Sci. 2021 Apr 26;22(9):4508. doi: 10.3390/ijms22094508. Int J Mol Sci. 2021. PMID: 33925942 Free PMC article.
-
Ultrastructural localization of proteoglycans in bone in osteogenesis imperfecta as demonstrated by Cuprolinic Blue staining.J Bone Miner Metab. 2002;20(5):288-93. doi: 10.1007/s007740200041. J Bone Miner Metab. 2002. PMID: 12203034
-
Defective association between collagen fibrils and proteoglycans in fragile bone of osteogenesis imperfecta.Clin Orthop Relat Res. 1988 Jul;(232):284-91. Clin Orthop Relat Res. 1988. PMID: 3383494
-
Bone Quality and Mineralization and Effects of Treatment in Osteogenesis Imperfecta.Calcif Tissue Int. 2024 Dec;115(6):777-804. doi: 10.1007/s00223-024-01263-8. Epub 2024 Sep 4. Calcif Tissue Int. 2024. PMID: 39231826 Review.
-
The bone cell biology of osteogenesis imperfecta.Connect Tissue Res. 1995;31(4):269-73. doi: 10.3109/03008209509010821. Connect Tissue Res. 1995. PMID: 15612366 Review.
Cited by
-
The biology of osteocytes.Curr Osteoporos Rep. 2007 Jun;5(2):81-6. doi: 10.1007/s11914-007-0007-z. Curr Osteoporos Rep. 2007. PMID: 17521510 Review.
-
A Clinical Perspective on Advanced Developments in Bone Biopsy Assessment in Rare Bone Disorders.Front Endocrinol (Lausanne). 2020 Jun 23;11:399. doi: 10.3389/fendo.2020.00399. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32714279 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical